Jin-Moo Lee Selected Research

splenotritin (TP3)

1/2011	Early changes of tissue perfusion after tissue plasminogen activator in hyperacute ischemic stroke.
2/2003	Magnetic resonance cerebral metabolic rate of oxygen utilization in hyperacute stroke patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jin-Moo Lee Research Topics

Disease

44	Stroke (Strokes) 05/2024 - 01/2002
24	Ischemic Stroke 05/2023 - 01/2002
23	Alzheimer Disease (Alzheimer's Disease) 02/2024 - 01/2004
15	Amyloid Plaque 02/2024 - 01/2004
11	Infarction (Infarctions) 07/2023 - 02/2003
8	Sickle Cell Anemia (Hemoglobin S Disease) 03/2024 - 01/2018
8	Edema (Dropsy) 07/2023 - 01/2016
8	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 09/2022 - 09/2003
7	Neoplasms (Cancer) 05/2023 - 12/2019
6	Ischemia 01/2022 - 04/2003
6	Cerebral Hemorrhage 01/2020 - 12/2007
6	Hemorrhage 01/2020 - 09/2003
4	Cognitive Dysfunction 02/2024 - 11/2020
4	Brain Edema (Cerebral Edema) 07/2023 - 01/2016
4	Cardiotoxicity 05/2023 - 02/2020
4	Nervous System Diseases (Neurological Disorders) 01/2022 - 03/2008
4	Inflammation (Inflammations) 07/2021 - 06/2015
4	Brain Injuries (Brain Injury) 01/2021 - 09/2006
3	Hypertension (High Blood Pressure) 09/2022 - 01/2019
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2021 - 01/2021
3	Cold Hypersensitivity 04/2019 - 01/2017
2	Fatigue 01/2023 - 09/2021
2	Cerebral Small Vessel Diseases 09/2022 - 01/2022
2	Hypoxia (Hypoxemia) 01/2022 - 09/2012
2	Anemia 01/2022 - 10/2018
2	Hematoma 07/2021 - 01/2012
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 05/2011
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 01/2019
2	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2016 - 06/2010
2	Multiple Sclerosis 01/2016 - 03/2008
2	Gliosis 06/2015 - 03/2008
2	Neuroblastoma 03/2015 - 01/2011
2	Carotid Stenosis (Carotid Artery Stenosis) 03/2014 - 01/2013
2	Dysmenorrhea (Menstrual Pain) 01/2014 - 06/2009
2	Diarrhea 01/2013 - 10/2011
2	Mitochondrial Diseases (Mitochondrial Disease) 02/2006 - 11/2005
1	Sleep Wake Disorders 01/2024
1	Cardiac Arrhythmias (Arrythmia) 05/2023
1	Pain (Aches) 01/2023
1	Thrombosis (Thrombus) 01/2023
1	Neuroinflammatory Diseases 01/2023
1	Brain Ischemia (Cerebral Ischemia) 01/2023
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2023
1	Arteriolosclerosis 09/2022
1	Venous Thrombosis (Deep-Vein Thrombosis) 08/2022
1	Sickle Cell Trait 01/2022
1	Disease Progression 01/2022
1	Embolic Stroke 01/2022

Drug/Important Bio-Agent (IBA)

19	Oxygen (Dioxygen)IBA 03/2024 - 02/2003
19	Biomarkers (Surrogate Marker)IBA 03/2024 - 09/2006
16	Amyloid (Amyloid Fibrils)IBA 02/2024 - 10/2006
12	Tissue Plasminogen Activator (Alteplase)FDA Link 07/2023 - 01/2011
11	Amyloid beta-PeptidesIBA 05/2023 - 01/2004
9	Proteins (Proteins, Gene)FDA Link 04/2021 - 11/2005
7	Peptides (Polypeptides)IBA 06/2021 - 07/2008
4	Matrix Metalloproteinases (MMPs)IBA 07/2021 - 08/2006
4	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2017
3	thiazolyl blueIBA 03/2022 - 02/2020
3	Neuroprotective AgentsIBA 01/2021 - 01/2002
3	Matrix Metalloproteinase 9 (Gelatinase B)IBA 06/2015 - 09/2003
3	NeurocalcinIBA 08/2011 - 09/2006
2	Chimeric Antigen ReceptorsIBA 02/2024 - 05/2023
2	Indicators and Reagents (Reagents)IBA 05/2023 - 01/2016
2	Complement System Proteins (Complement)IBA 08/2022 - 01/2021
2	Ether (Diethyl Ether)IBA 02/2022 - 02/2020
2	EnzymesIBA 01/2022 - 09/2003
2	CalciumIBA 01/2022 - 01/2017
2	dimethyl sulfone (methylsulfonylmethane)IBA 10/2021 - 05/2021
2	SulfurIBA 10/2021 - 05/2021
2	LipopolysaccharidesIBA 05/2021 - 01/2021
2	gingerolIBA 04/2021 - 01/2021
2	IronIBA 01/2021 - 01/2021
2	Serotonin (5 Hydroxytryptamine)IBA 11/2020 - 05/2014
2	Retinaldehyde (Retinal)IBA 10/2020 - 07/2013
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2019 - 05/2011
2	CytokinesIBA 01/2019 - 06/2005
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019 - 01/2002
2	Small Interfering RNA (siRNA)IBA 09/2012 - 11/2005
2	splenotritin (TP3)IBA 01/2011 - 02/2003
1	AntibodiesIBA 02/2024
1	Monoclonal AntibodiesIBA 05/2023
1	BuffersIBA 01/2023
1	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2023
1	Blocking AntibodiesIBA 01/2023
1	Blood Group Antigens (Blood Groups)IBA 08/2022
1	2- (4- iodo- 2,5- dimethoxyphenyl)- N- (2- methoxybenzyl)ethanamineIBA 03/2022
1	Phosphotransferases (Kinase)IBA 03/2022
1	25C-NBOHIBA 02/2022
1	N- (2- hydroxybenzyl)- 2- (4- iodo- 2,5- dimethoxyphenyl)ethan- 1- aminiumIBA 02/2022
1	AnticoagulantsIBA 01/2022
1	Glutamic Acid (Glutamate)FDA Link 01/2022

Therapy/Procedure

20	Therapeutics 05/2024 - 01/2002
7	Thrombectomy 01/2021 - 01/2017
5	Thrombolytic Therapy 01/2021 - 01/2002
4	Immunotherapy 02/2024 - 01/2021
2	Activities of Daily Living (ADL) 01/2024 - 01/2022
2	East Asian Traditional Medicine (Oriental Medicine) 09/2021 - 06/2009
2	Blood Transfusion (Blood Transfusions) 10/2019 - 01/2018
2	Carotid Endarterectomy 03/2014 - 01/2013
1	Splenectomy 01/2022